Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1) Peptid
LZTS1
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN979692
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 15 bis 22 Werktagen
Kurzübersicht für Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1) Peptid (ABIN979692)
Target
LZTS1
(Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-LZTS1 antibody (Catalog #: ARP39473_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- LZTS1 (Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1))
-
Hintergrund
-
LZTS1 involved in the regulation of cell growth. LZTS1 may stabilize the active CDC2-cyclin B1 complex and thereby contribute to the regulation of the cell cycle and the prevention of uncontrolled cell proliferation. LZTS1 may act as tumor suppressor and defects in LZTS1 are found in many types of tumors.
Alias Symbols: F37, FEZ1
Protein Interaction Partner: CDC25C,CDK1,EEF1G,CDK1,EEF1G
Protein Size: 596 -
Molekulargewicht
- 67 kDa
-
Gen-ID
- 11178
-
NCBI Accession
- NM_021020, NP_066300
-
UniProt
- Q9Y250
Target
-
Sie sind hier:
